Dexamethasone Patent Expiration
Dexamethasone is Used for treating eye conditions such as diabetic macular edema, macular edema, non-infectious uveitis, and uveitis by delivering an ocular implant. It was first introduced by Merck And Co Inc
Dexamethasone Patents
Given below is the list of patents protecting Dexamethasone, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Dextenza | US11458041 | Punctal plug and bioadhesives | Nov 16, 2037 | Ocular Therapeutix |
| Dextenza | US8409606 | Drug delivery through hydrogel plugs | May 14, 2030 | Ocular Therapeutix |
| Dextenza | US8563027 | Drug delivery through hydrogel plugs | Feb 12, 2030 | Ocular Therapeutix |
| Dextenza | US9254267 | Composite hydrogel drug delivery systems | Sep 11, 2024 | Ocular Therapeutix |
| Dexycu Kit | US10022502 | Dose guides for injection syringe | Jun 22, 2034 | Eyepoint Pharms |
| Dexycu Kit | US10028965 | Use of sustained release dexamethasone in post-cataract surgery inflammation | May 23, 2034 | Eyepoint Pharms |
| Dexycu Kit | US10159683 | Use of sustained release dexamethasone in post-cataract surgery inflammation | May 23, 2034 | Eyepoint Pharms |
| Dexycu Kit | US10799642 | Dose guides for injection syringe | May 11, 2032 | Eyepoint Pharms |
| Dexycu Kit | US11097061 | Systems, kits and methods for loading and delivering a small volume dose from a syringe | Jun 23, 2039 | Eyepoint Pharms |
| Dexycu Kit | US6960346 | Vehicles for delivery of biologically active substances |
Jul 03, 2023
(Expired) | Eyepoint Pharms |
| Dexycu Kit | US7560120 | Vehicles for delivery of biologically active substances |
Sep 05, 2022
(Expired) | Eyepoint Pharms |
| Hemady | US10537585 | Compositions comprising dexamethasone | Dec 18, 2037 | Dexcel |
| Hemady | US11304961 | Compositions comprising dexamethasone | Dec 18, 2037 | Dexcel |
| Ozurdex | US10076526 | Ocular implant made by a double extrusion process |
Jan 09, 2023
(Expired) | Abbvie |
| Ozurdex | US10702539 | Ocular implant made by a double extrusion process |
Jan 09, 2023
(Expired) | Abbvie |
| Ozurdex | US6726918 | Methods for treating inflammation-mediated conditions of the eye |
Oct 20, 2020
(Expired) | Abbvie |
| Ozurdex | US6899717 | Methods and apparatus for delivery of ocular implants |
Nov 01, 2023
(Expired) | Abbvie |
| Ozurdex | US7033605 | Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
Oct 20, 2020
(Expired) | Abbvie |
| Ozurdex | US7767223 | Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use |
Nov 28, 2021
(Expired) | Abbvie |
| Ozurdex | US8034366 | Ocular implant made by a double extrusion process |
Jan 09, 2023
(Expired) | Abbvie |
| Ozurdex | US8034370 | Ocular implant made by a double extrusion process |
Jan 09, 2023
(Expired) | Abbvie |
| Ozurdex | US8043628 | Methods for reducing edema |
Oct 20, 2020
(Expired) | Abbvie |
| Ozurdex | US8063031 | Implants and methods for treating inflammation-mediated conditions of the eye |
Oct 20, 2020
(Expired) | Abbvie |
| Ozurdex | US8088407 | Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
Oct 20, 2020
(Expired) | Abbvie |
| Ozurdex | US8506987 | Ocular implant made by a double extrusion process |
Jan 09, 2023
(Expired) | Abbvie |
| Ozurdex | US9012437 | Implants and methods for treating inflammation-mediated conditions of the eye |
Oct 20, 2020
(Expired) | Abbvie |
| Ozurdex | US9192511 | Ocular implant made by a double extrusion process |
Jan 09, 2023
(Expired) | Abbvie |
| Ozurdex | US9283178 | Methods for treating edema in the eye and intraocular implants for use therefor |
Oct 20, 2020
(Expired) | Abbvie |
| Ozurdex | US9592242 | Methods for treating edema in the eye and intraocular implants for use therefor |
Oct 20, 2020
(Expired) | Abbvie |
| Ozurdex | US9775849 | Implants and methods for treating inflammation-mediated conditions of the eye |
Oct 20, 2020
(Expired) | Abbvie |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Dexamethasone Generics
Several generic applications have been filed for Dexamethasone. The first generic version for Dexamethasone was by Sun Pharmaceutical Industries Inc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Zydus Lifesciences Ltd and was approved on May 9, 2024.
Given below is the list of companies who have filed for Dexamethasone generic.
1. AMNEAL
Amneal Eu Ltd has filed for 3 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Amneal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 4MG | tablet | Prescription | ORAL | AB | Oct 14, 2021 |
| 6MG | tablet | Prescription | ORAL | AB | Oct 14, 2021 |
| 2MG | tablet | Prescription | ORAL | AB | Sep 8, 2022 |
2. IMPAX LABS
Impax Laboratories Inc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Impax Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.75MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
3. ALPHARMA US PHARMS
Alpharma Us Pharmaceuticals Division has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Alpharma Us Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.5MG/5ML | elixir | Discontinued | ORAL | N/A | Oct 10, 1986 |
4. APOTEX
Apotex Inc has filed for 7 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Apotex.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.5MG | tablet | Prescription | ORAL | AB | Aug 23, 2023 |
| 6MG | tablet | Prescription | ORAL | AB | Aug 23, 2023 |
| 4MG | tablet | Prescription | ORAL | AB | Aug 23, 2023 |
| 2MG | tablet | Prescription | ORAL | AB | Aug 23, 2023 |
| 0.5MG | tablet | Prescription | ORAL | AB | Aug 23, 2023 |
| 0.75MG | tablet | Prescription | ORAL | AB | Aug 23, 2023 |
| 1MG | tablet | Prescription | ORAL | AB | Aug 23, 2023 |
5. PHOENIX LABS NY
Phoenix Laboratories Inc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Phoenix Labs Ny.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.75MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
6. PRASCO
Prasco Llc Dba Prasco Laboratories has filed for 2 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Prasco.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.75MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
| 4MG | tablet | Prescription | ORAL | AB | Apr 20, 2022 |
7. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 9 different strengths of generic version for Dexamethasone. Out of these 1mg/ml version comes by the name DEXAMETHASONE INTENSOL. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.5MG
(reference listed drug) | tablet | Prescription | ORAL | AB | Approved Prior to Jan 1, 1982 |
| 0.5MG
(reference listed drug) | tablet | Prescription | ORAL | AB | Approved Prior to Jan 1, 1982 |
| 4MG
(reference listed drug) | tablet | Prescription | ORAL | AB | Approved Prior to Jan 1, 1982 |
| 0.75MG
(reference listed drug) | tablet | Prescription | ORAL | AB | Approved Prior to Jan 1, 1982 |
| 2MG
(reference standard) (reference listed drug) | tablet | Prescription | ORAL | AB | Aug 26, 1982 |
| 0.5MG/5ML
(reference standard) (reference listed drug) | solution | Prescription | ORAL | N/A | Sep 1, 1983 |
| 1MG/ML
(reference standard) | concentrate | Prescription | ORAL | N/A | Sep 1, 1983 |
| 6MG
(reference standard) (reference listed drug) | tablet | Prescription | ORAL | AB | Sep 15, 1983 |
| 1MG
(reference standard) (reference listed drug) | tablet | Prescription | ORAL | AB | Sep 15, 1983 |
8. WATSON LABS
Watson Laboratories Inc has filed for 5 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Watson Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.75MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
| 0.25MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
| 0.5MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
| 1.5MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
| 0.1% | suspension/drops | Discontinued | OPHTHALMIC | N/A | May 9, 1989 |
9. ZYDUS LIFESCIENCES
Zydus Lifesciences Ltd has filed for 7 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.75MG | tablet | Prescription | ORAL | AB | Feb 7, 2024 |
| 0.5MG | tablet | Prescription | ORAL | AB | Feb 7, 2024 |
| 4MG | tablet | Prescription | ORAL | AB | Feb 7, 2024 |
| 6MG | tablet | Prescription | ORAL | AB | Feb 7, 2024 |
| 2MG | tablet | Prescription | ORAL | AB | Feb 7, 2024 |
| 1.5MG | tablet | Prescription | ORAL | AB | Feb 7, 2024 |
| 1MG | tablet | Prescription | ORAL | AB | May 9, 2024 |
10. KEY THERAP
Key Therapeutics Llc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Key Therap.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.5MG | tablet | Discontinued | ORAL | N/A | Apr 28, 1983 |
11. ALLERGAN HERBERT
Allergan Herbert Div Allergan Inc has filed for 1 generic for Dexamethasone. This 0.01% **federal register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** version comes by the name AEROSEB-DEX. Given below are the details of the strengths of this generic introduced by Allergan Herbert.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.01% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | aerosol | Discontinued | TOPICAL | N/A | Approved Prior to Jan 1, 1982 |
12. SOLVAY
Solvay Pharmaceuticals has filed for 4 different strengths of generic version for Dexamethasone. Out of these 1.5mg version comes by the name DEXONE 1.5, 0.5mg version comes by the name DEXONE 0.5, 4mg version comes by the name DEXONE 4, 0.75mg version comes by the name DEXONE 0.75. Given below are the details of the strengths of this generic introduced by Solvay.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.5MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
| 0.5MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
| 4MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
| 0.75MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
13. WHITEWORTH TOWN PLSN
Whiteworth Towne Paulsen Inc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Whiteworth Town Plsn.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.75MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
14. UPSHER SMITH
Upsher Smith Laboratories Inc has filed for 2 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Upsher Smith.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.5MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
| 0.75MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
15. BIONPHARMA
Bionpharma Inc has filed for 3 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Bionpharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 6MG | tablet | Prescription | ORAL | AB | Apr 19, 2023 |
| 4MG | tablet | Prescription | ORAL | AB | Apr 19, 2023 |
| 2MG | tablet | Prescription | ORAL | AB | Apr 26, 2023 |
16. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.5MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
17. ROXANE
Roxane Laboratories Inc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Roxane.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.25MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
18. PANGEA
Pangea Pharmaceuticals Llc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Pangea.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.25MG | tablet | Discontinued | ORAL | N/A | Apr 28, 1983 |
19. LYNE
Lyne Laboratories Inc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Lyne.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.5MG/5ML | elixir | Prescription | ORAL | AA | Jul 12, 2011 |
20. BAUSCH
Bausch Health Americas Inc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Bausch.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.5MG | tablet | Discontinued | ORAL | N/A | Aug 15, 2008 |
21. SUN PHARM INDUSTRIES
Sun Pharmaceutical Industries Inc has filed for 4 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Sun Pharm Industries.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.75MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
| 0.25MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
| 0.5MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
| 1.5MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
22. ALVOGEN
Alvogen Inc has filed for 4 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Alvogen.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.75MG | tablet | Prescription | ORAL | BP | Apr 28, 1983 |
| 0.5MG | tablet | Prescription | ORAL | BP | Apr 28, 1983 |
| 4MG | tablet | Prescription | ORAL | AB | Apr 28, 1983 |
| 6MG | tablet | Prescription | ORAL | AB | Nov 28, 1983 |
23. LARKEN LABS INC
Larken Laboratories Inc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Larken Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.5MG | tablet | Prescription | ORAL | AB | Jul 17, 2017 |
24. NOVITIUM PHARMA
Novitium Pharma Llc has filed for 6 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Novitium Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 4MG | tablet | Prescription | ORAL | AB | Aug 8, 2022 |
| 1.5MG | tablet | Prescription | ORAL | AB | Aug 8, 2022 |
| 6MG | tablet | Prescription | ORAL | AB | Aug 8, 2022 |
| 2MG | tablet | Prescription | ORAL | AB | May 9, 2023 |
| 0.75MG | tablet | Prescription | ORAL | AB | Oct 5, 2023 |
| 0.5MG | tablet | Prescription | ORAL | AB | Oct 5, 2023 |
25. PVT FORM
Private Formulations Inc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Pvt Form.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.75MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
26. CHARTWELL MOLECULAR
Chartwell Molecular Holdings Llc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.5MG/5ML | elixir | Prescription | ORAL | AA | May 11, 2011 |
27. ANIMA
Anima Pharmaceuticals Pvt Ltd has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Anima.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.5MG/5ML
(reference standard) | elixir | Prescription | ORAL | AA | Approved Prior to Jan 1, 1982 |
28. PAR PHARM
Par Pharmaceutical Inc has filed for 3 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Par Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.75MG | tablet | Prescription | ORAL | BP | Apr 28, 1983 |
| 4MG | tablet | Prescription | ORAL | BP | Apr 28, 1983 |
| 0.5MG | tablet | Prescription | ORAL | BP | Apr 28, 1983 |
29. PHARMOBEDIENT CNSLTG
Pharmobedient Consulting has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Pharmobedient Cnsltg.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.5MG/5ML
(reference listed drug) | elixir | Discontinued | ORAL | N/A | Jul 27, 1983 |